A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
Sean Nolan(Adaptive Biotechnologies (United States)), Harlan Robins(Adaptive Biotechnologies (United States)), Jason D. Goldman(University of Washington), Mark Klinger, Santiago Barrio, Katie Boland(Adaptive Biotechnologies (United States)), Ottavia M. Delmonte(National Institutes of Health), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Kerry Dobbs(National Institute of Allergy and Infectious Diseases), Jonathan M. Carlson(Microsoft (United States)), Fabio Nicolini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Simona Semprini(University of Bologna), Christopher J. Gooley(Microsoft Research (United Kingdom)), Rachel M. Gittelman(Adaptive Biotechnologies (United States)), Emily Svejnoha(Adaptive Biotechnologies (United States)), Thomas M. Snyder(Adaptive Biotechnologies (United States)), Claudio Cerchione(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Martinelli(University of Bologna), Gonzalo Carreño‐Tarragona, Mitchell W. Pesesky(Adaptive Biotechnologies (United States)), Marissa Vignali(Adaptive Biotechnologies (United States)), Jennifer N. Dines(Adaptive Biotechnologies (United States)), Tracy Craft(Adaptive Biotechnologies (United States)), James R. Heath(Institute for Systems Biology), Bryan Howie(Unknown), Ian M. Kaplan(Adaptive Biotechnologies (United States)), Luigi D. Notarangelo(Unknown), Massimiliano Mazza(University of Milan)
Cited by 50
Related Papers
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
|Nature Genetics|2012|1.9k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k